NSAV Announces the Formal Execution of a Letter of Intent

New Post Public Reply Private Reply Replies (0) Message Board
aliangel
NSAV Announces the Formal Execution of a Letter of Intent to Acquire Bella Vida Brands, Inc.

Nov 07, 2014 (eTeligis.com via COMTEX) -- PORT JEFFERSON, NY, United States, via ETELIGIS INC., 11/07/2014 - - Net Savings Link, Inc. (OTC Pink: NSAV) (PINKSHEETS: NSAV), today has announced the formal execution of a Letter of Intent to acquire Bella Vida Brands, Inc., a firm with decades of deep roots in the Artisanal food and beverage/wellness/ and retail distribution space in the Northeastern portion of the U.S., and which is now expanding nationally.
Steven Baritz, the CEO of NSAV said, "Our due diligence evaluation of this firm was undertaken via a previously announced agreement by NSAV's new President, Leonard. F. Genovese, and the findings of the evaluation support the viability, sustainability, and projected earnings expectations that NSAV required in order to move to next steps in the acquisition of Bella Vida Brands, Inc." Mr. Baritz continued, "Bella Vida Brands is projected to show over $510,000 in sales for fiscal year ending 2014, and is projected to have expected sales of $1.5 - $1.7 Million in sales for fiscal year ending 2015."

NSAV's President, Mr. Leonard F. Genovese commented; "Bella Vida Brands brings a significant variety in Artisanal food and beverage products that has an established and growing track record of quality, deliverability, and market penetration." Mr. Genovese continued, "Their products are unique and of exceptional quality, and are imported from around the world to provide a product quality that has received rave reviews from major restaurants and distribution networks, including their introduction at prime events such as New York's City Hall, and related events."

Mr. Nicholas Dunn, the Sr. Director of Operations and Product Research for Bella Vida commented, "Bella Vida Brands is excited about the opportunity to merge into a public entity that has such an experienced management team, including Mr. Leonard F. Genovese of the Genovese drug store chain. We are confident that the merger of our two entities will provide enhanced distribution channels and market exposure for Bella Vida Brands, and the ability to raise capital as a public venue will enable Bella Vida to add significant inventory and brand exposure to the marketplace."

Steven Baritz, the CEO of NSAV said, "Fox Business News Small Business Center has provided researched input into the Artisanal food and beverage space, and their findings showed that Artisanal and specialty food sales have soared by 19.1% since 2011, according to the National Association for the Specialty Food Trade. Additionally, the research firm Packaged Facts reports that nearly 46% of U.S. Adults agree or strongly agree that they "like to eat food or beverage products with artisan appeal." Mr. Baritz continued, "Clearly, these findings from these reputable sources dovetail with our own due diligence evaluation of this space, and more particularly, with Bella Vida Brands as that partner for NSAV in that space." Baritz continued, "More press releases will be forthcoming as we close on this acquisition, which we expect to complete by year's end 2014."

Mr. Baritz and Mr. Genovese also further commented on a previous recent release regarding the removal of the DTC chill, "Growth and revenue opportunities like the one that is expected as a result of this Bella Vida merger will clearly require NSAV to have more exposure to the various brokerage markets available to shareholders and investors nationwide and internationally. Accordingly, NSAV is continuing to make one of its top priorities, the removal of the DTC chill that has existed, as referenced in a prior release, prior to the current management team's tenure on the Board." Baritz and Genovese jointly continued, "As mentioned in a prior release, we expect to commence the process to remove the chill as soon as certain self- imposed metrics are achieved in regard to capital availability and revenue expectations."

About Net Savings Link, Inc.

Net Savings Link, Inc. owns and operates a wholly owned subsidiary, Global Distribution Corporation, a distribution company that markets and distributes products in varying industries including the supplement, wellness and natural remedies markets. People interested in learning more about Global Distribution should check back with the company at its website, www.Globaldistributioncorp.net .

About Bella Vida Brands, Inc.

Bella Vida Brands has decades of experience in the Artisanal food and beverage industry, and they import the most unique products from around the world in order to find the highest quality food manufacturers and products that other companies can't compete with. They have an extensive line of products from Italy, and they bring rapid delivery across all of their product lines. Their sourcing capability is in continual expansion mode, providing a continual growth model to keep their products relevant with market needs and trends. Anyone interested in more information on Bella Vida Brands can visit their website at www.Bellavidabrands.com

DISCLAIMER:

This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information contained in this Press Release including such forward-looking statements.

CONTACT:

David Pecoraro,

Shareholder Relations Director

Email: DavidPecoraro@rocketmail.com

Tel : 814-418-6648

SOURCE: Net Savings Link, Inc.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Astemo Flexes Aftermarket Muscles at 2026 AAPEX & SEMA

Updated Category News Views 90

Ah, nothing gets car enthusiasts more revved up than a good old-fashioned auto show unveiling. Astemo Americas is strutting its stuff at the 2026 AAPEX and SEMA shows, and they're not just shooting the breeze—this company has got some serious aftermarket muscle to flex. Pumping Up the Aftermarket Game Astemo's not sitting on its hands when it comes to expanding its...

Continue Reading
Ping An Shows Resilient Growth Amid Economic Pressure

Updated Category News Views 18

Unpacking Ping An's Steady Climb Amid Tumult A few eyebrows might have raised when Ping An Insurance unveiled its nine-month report for 2026. Despite economic turbulence in China—courtesy of a gnarly global scene—the numbers were anything but rattled. Operating profit rose 8.3% year over year to a beefy RMB125,905 million. The equity pool swelled by 4.4% as of...

Continue Reading
Beacon AI's Murdock Flies into the Future for USAF

Updated Category News Views 69

Advancing AI in the Skies Nothing quite shakes up the aviation scene like a debut flight of a new AI system aboard real-deal military planes. Beacon AI is throwing down its AI pilot assistant system, Murdock, on the table—its pride and joy just completed five flights on KC-46A Pegasus craft, sanctioned by no less than the U.S. Air Force itself. Grit and Innovation: The...

Continue Reading
Lynk Pharmaceuticals' Zemprocitinib Shines in Phase III RA Trial

Updated Category News Views 86

A Deep Dive into Lynk Pharmaceuticals' Latest Revelation Lynk Pharmaceuticals just dropped a bombshell with their latest Phase III trial results for zemprocitinib. This selective JAK1 inhibitor seems to be bringing some serious game in the fight against moderate-to-severe rheumatoid arthritis (RA), especially for folks who haven't had much luck with biologics. The drug...

Continue Reading
Baystate Health's Pilot Eases Access to Medical Services

Updated Category News Views 98

Rethinking Healthcare Access with Baystate Health Now here's a bit of news that doesn't make you wanna choke on your coffee: Baystate Health's Clear Path Pilot Program is shaking things up in the healthcare game, and it's about time. The initiative, rolling out with Health New England, is like waving a magic wand over the usual bureaucratic mess of prior authorizations....

Continue Reading
Astellas and Audax Forge $1.34B Immuno-Oncology Deal

Updated Category News Views 100

Big Moves in Immuno-Oncology: Astellas' Latest Bet You hear 'immuno-oncology,' you think breakthrough, right? Well, friends, that's what Astellas and Audax Biosciences are shooting for with their fresh handshake over DAX-044. On October 27, 2026, in Tokyo and Melbourne, the two outfits announced they're joining forces to bring this novel immunotherapy to the table. It's...

Continue Reading
Singapore's New Leap in Healthcare Innovation with IMDA-NUH Partnership

Updated Category News Views 0

A Groundbreaking Partnership in Singapore's Healthcare Sector Every so often, something big comes along that makes you stop and take notice. This time, it's the alliance between the Infocomm Media Development Authority (IMDA) and the National University Hospital (NUH) in Singapore. By launching an Open Innovation Platform (OIP) partnership, they've embarked on a journey...

Continue Reading
OppFi's Q3 2026: Is Their Growth Strategy on Track?

Updated Category News Views 14

OppFi's Third Quarter Performance Unpacked OppFi's recent third-quarter disclosures should get investors pondering. They've launched a new line of credit product, plugging a gap in their service portfolio, and aimed to widen their customer net. Their targeted share repurchase of $6.7 million in stock isn't small potatoes either, showing a vote of confidence in their own...

Continue Reading
Lennox Faces Pressures Amidst Strong Revenue Growth

Updated Category News Views 0

Revenue Surge but Margin Squeeze Out there in the land of HVAC, Lennox International (NYSE: LII) just dropped its third quarter earnings for 2026. Sure, they raked in a solid $1.6 billion—up a hearty 10%. But all that glitters ain't gold, and the company's operating income took a hit down to $312 million, shedding a cool five percent from last year. Challenges Weighing...

Continue Reading
Digimon Card Game Ventures into Digital Realms

Updated Category News Views 40

A Bold Leap for the Digimon Card Game Folks, if you've been tapping your foot waiting for Digimon to fire up a serious digital game, well, here's your moment. BANDAI CO., LTD. is rolling the dice as they launch pre-registration for DIGIMON ALYSION, a digital twist on the classic card game, across 49 countries. It's not just a game; it's a reimagining. They're not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Ripple Banking License: Unlocking New Opportunities for XRP

Updated Category News Views 129

Ripple Banking License: Unlocking New Opportunities for XRP In recent developments, Ripple is on the brink of obtaining a banking license, a significant milestone that promises to reshape its role within the traditional financial sector. This pivotal moment not only ratifies Ripple’s credibility but also enhances the use of XRP among its holders. The acquisition of a...

Continue Reading
SEI's Dividend: $0.52 a Share May 2026 Call

Updated Category News Views 22

SEI's Dividends Sweeten the Pot In a world where every market shift feels like someone moving your chair just as you sit down, SEI Investments (NASDAQ: SEIC) keeps a consistent beat. They've declared a semi-annual dividend of $0.52 per share, and let me tell you, that's music to any income-seeking investor's ears right now. Those looking for steady returns in this...

Continue Reading
Solana Experiences a Significant Price Surge of 6.18%

Updated Category News Views 48

Solana price jumps 6.18% to $134.95 Solana added 6.18% in the latest session, bringing the price to $134.95. The move points to firm trading momentum as the market keeps a close eye on SOL. Gains like this usually appear when interest broadens and activity picks up, even if the day-to-day path isn’t perfectly smooth. One-week trend: steady gains from $130.33 Beyond the...

Continue Reading
BD Strengthens Future Plans with Strategic Business Separation

Updated Category News Views 1181

BD Announces Strategic Separation of Business Units BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has taken a bold step by announcing a plan to separate its Biosciences and Diagnostics Solutions divisions from the rest of the organization. This strategic separation aims to enhance focus, drive growth, and unlock substantial...

Continue Reading
Understanding Solana's Recent Price Decline and Market Impact

Updated Category News Views 273

Analyzing Solana's Price Drop In the last day, Solana has encountered a significant decrease in its price, falling by more than 9% and currently valued at $120.87. This price drop is part of a broader downward trend observed over the past week, where the cryptocurrency recorded a staggering loss of 22%. The decline in value from $157.77 to its present figure illustrates...

Continue Reading